In addition to the known risk factors of chemotherapy and radiation exposure, history of autoimmune disease and granulocyte-colony stimulating factor exposure emerged as consistent predictors of tMN after each of the 5 cancers in the study. The gene discussed is CSF3; the disease is autoimmune disease.